Effects of short-term dexamethasone administration on corticospinal excitability

Medicine and Science in Sports and Exercise

Volumn 46, Issue 4, 2014, Pages 695-701

  Baudry, Stéphane ^a   Lanfranco, Fabio ^b   Merletti, Roberto ^c   Duchateau, Jacques ^a   Minetto, Marco A ^b,c  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF TURIN   (Italy)

^c POLITECNICO DI TORINO   (Italy)

Author keywords

corticospinal excitability; Dexamethasone; maximal voluntary force; surface electromyography; tibialis anterior muscle; transcranial magnetic stimulation

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE;

ADULT; ANKLE; CHEMISTRY; CONTROLLED STUDY; DRUG EFFECTS; ELECTROMYOGRAPHY; ELECTROSTIMULATION; HOFFMANN REFLEX; HUMAN; MALE; MOTOR EVOKED POTENTIAL; MUSCLE CONTRACTION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SALIVA; SINGLE BLIND PROCEDURE; SKELETAL MUSCLE; TORQUE; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

ADULT; ANKLE; DEXAMETHASONE; ELECTRIC STIMULATION; ELECTROMYOGRAPHY; EVOKED POTENTIALS, MOTOR; GLUCOCORTICOIDS; H-REFLEX; HUMANS; HYDROCORTISONE; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; SALIVA; SINGLE-BLIND METHOD; TORQUE; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 84897065252     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0000000000000162     Document Type: Article

References (28)

1. Baudry S, Duchateau J. Postactivation potentiation in human muscle is not related to the type of maximal conditioning contraction. Muscle Nerve. 2004;30:328-36.
2. Duclay J, Pasquet B, Martin A, Duchateau J. Specific modulation of corticospinal and spinal excitabilities during maximal voluntary isometric, shortening and lengthening contractions in synergist muscles. J Physiol. 2011;589:2901-16.
3. Duclos M. Evidence on ergogenic action of glucocorticoids as a doping agent risk. Phys Sportsmed. 2010;38:121-7.
4. Dvorak J, Feddermann N, Grimm K. Glucocorticosteroids in football: use and misuse. Br J Sports Med. 2006;40(1 Suppl): i48-i54.
5. Florian J, Muller-Dahlhaus M, Liu Y, Ziemann U. Inhibitory circuits and the nature of their interactions in the human motor cortex a pharmacological TMS study. J Physiol. 2008;586:495-514.
6. Hall ED, Baker T, Riker WF Jr. Glucocorticoid effects on spinal cord function. J Pharmacol Exp Ther. 1978;2060:361-70
7. Hall ED. Glucocorticoid effects on serotonergic and noradrenergic facilitation of spinal monosynaptic transmission. Psychiatry Res. 1980;2:241-50
8. Hall ED. Glucocorticoid enhancement of serotonergic facilitation of cat spinal monosynaptic motor neuron excitation. Exp Neurol. 1980;68:589-94
9. Hall ED. Glucocorticoid effects on the electrical properties of spinal motor neurons. Brain Res. 1982;240:109-16.
10. Hall ED, Baker T. Acute effects of methylprednisolone sodium succinate on spinal reflexes. Exp Neurol. 1979;63:476-84.
11. Hall ED, Baker T. Further studies of glucocorticoid effects on spinal cord function: single and repetitive monosynaptic transmission and apparent Ia afferent transmitter turnover. J Pharmacol Exp Ther. 1979;210:112-5.
12. Hallett M. Transcranial magnetic stimulation: a primer. Neuron. 2007;55:187-99.
13. Macefield VG, Gandevia SC, Bigland-Ritchie B, Gorman RB, Burke D. The firing rates of human motoneurones voluntarily activated in the absence of muscle afferent feedback. J Physiol. 1993;471:429-43.
14. MacIntosh BR, Gardiner PF, McComas AJ. Skeletal Muscle. 2nd ed. Human Kinetics; 2006. pp. 160-6.
15. Milani P, Piu P, Popa T, et al. Cortisol-induced effects on human cortical excitability. Brain Stimul. 2010;3:131-9.
16. Minetto MA, Botter A, Lanfranco F, Baldi M, Ghigo E, Arvat E. Muscle fiber conduction slowing and decreased levels of circulating muscle proteins after short-term dexamethasone administration in healthy subjects. J Clin Endocrinol Metab. 2010;95:1663-71.
17. Morita H, Petersen N, Christensen LO, Sinkjaer T, Nielsen J. Sensitivity of H-reflexes and stretch reflexes to presynaptic inhibition in humans. J Neurophysiol. 1998;80:610-20.
18. Orth M, Rothwell JC. The cortical silent period: intrinsic variability and relation to the waveform of the transcranial magnetic stimulation pulse. Clin Neurophysiol. 2004;115:1076-82.
19. Pierrot-Deseilligny E, Mazevet D. The monosynaptic reflex: a tool to investigate motor control in humans. Interest and limits. Neurophysiol Clin. 2000;30:67-80.
20. Pigozzi F, Di Gianfrancesco A, Zorzoli M, et al. Why gluco- corticosteroids should remain in the list of prohibited substances: a sports medicine viewpoint. Int J Immunopathol Pharmacol. 2012;25:19-24.
21. Riker WF Jr, Baker T, Okamoto M. Glucocorticoids and mammalian motor nerve excitability. Arch Neurol. 1975;32:688-94.
22. Rothwell JC. Physiological studies of electric and magnetic stimulation of the human brain. Electroencephalogr Clin Neuro-physiol. 1991;43(Suppl):29-35.
23. Rudomin P, Schmidt RF. Presynaptic inhibition in the vertebrate spinal cord revisited. Exp Brain Res. 1999;129:1-37.
24. Sacco P, Thickbroom GW, Thompson ML, Mastaglia FL. Changes in corticomotor excitation and inhibition during prolonged sub-maximal muscle contractions. Muscle Nerve. 1997;20:1158-66.
25. Schieppati M. The Hoffmann reflex: a means of assessing spinal reflex excitability and its descending control in man. Prog Neurobiol. 1987;28:345-76.
26. van der Hoeven JH. Decline of muscle fiber conduction velocity during short-term high-dose methylprednisolone therapy. Muscle Nerve. 1996;19:100-2.
27. Wassermann EM. Variation in the response to transcranial magnetic brain stimulation in the general population. Clin Neurophysiol. 2002;113:1165-71.
28. Ziemann U. TMS and drugs. Clin Neurophysiol. 2004;115:1717-29.